Biomarkers for pediatric sepsis and septic shock

References

• Goldstein B, Giroir B, Randolph A International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in Pediatr. Crit. Care Med.6(1), 2–8 (2005).
   PubMedGoogle Scholar
• Levy MM, Fink MP, Marshall JC et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med.31(4), 1250–1256 (2003).
   PubMed Web of Science ®Google Scholar
• Dellinger RP, Levy MM, Carlet JM et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit. Care Med.36(1), 296–327 (2008).
   PubMed Web of Science ®Google Scholar
• Brierley J, Carcillo JA, Choong K et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit. Care Med.37(2), 666–688 (2009).
   PubMed Web of Science ®Google Scholar
• Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther.69(3), 89–95 (2001).
   PubMed Web of Science ®Google Scholar
• Marshall JC, Reinhart K. Biomarkers of sepsis. Crit. Care Med.37(7), 2290–2298 (2009).
   PubMed Web of Science ®Google Scholar
• Kaplan JM, Wong HR. Biomarker discovery and development in pediatric critical care medicine. Pediatr. Crit. Care Med. (2010) (Epub ahead of print).
   Google Scholar
• Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit. Care Med.36(3), 941–952 (2008).
   PubMed Web of Science ®Google Scholar
• Arkader R, Troster EJ, Lopes MR et al. Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome. Arch. Dis. Child.91(2), 117–120 (2006).
   PubMed Web of Science ®Google Scholar
• Casado-Flores J, Blanco-Quirós A, Asensio J et al. Serum procalcitonin in children with suspected sepsis: a comparison with C-reactive protein and neutrophil count. Pediatr. Crit. Care Med.4(2), 190–195 (2003).
   PubMedGoogle Scholar
• Fioretto JR, Martin JG, Kurokawa CS et al. Comparison between procalcitonin and C-reactive protein for early diagnosis of children with sepsis or septic shock. Inflamm. Res.59(8), 581–586 (2010).
   PubMed Web of Science ®Google Scholar
• Rey C, Los Arcos M, Concha A et al. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children. Intensive Care Med.33(3), 477–484 (2007).
   PubMed Web of Science ®Google Scholar
• Simon L, Saint-Louis P, Amre DK, Lacroix J, Gauvin F. Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome. Pediatr. Crit. Care Med.9(4), 407–413 (2008).
   PubMed Web of Science ®Google Scholar
• Carrol ED, Newland P, Thomson APJ, Hart CA. Prognostic value of procalcitonin in children with meningococcal sepsis. Crit. Care Med.33(1), 224–225 (2005).
   PubMed Web of Science ®Google Scholar
• Enguix A, Rey C, Concha A et al. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intensive Care Med.27(1), 211–215 (2001).
   PubMed Web of Science ®Google Scholar
• Groselj-Grenc M, Ihan A, Pavcnik-Arnol M et al. Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children. Intensive Care Med.35(11), 1950–1958 (2009).
   PubMed Web of Science ®Google Scholar
• Han YY, Doughty LA, Kofos D, Sasser H, Carcillo JA. Procalcitonin is persistently increased among children with poor outcome from bacterial sepsis. Pediatr. Crit. Care Med.4(1), 21–25 (2003).
   PubMedGoogle Scholar
• Hatherill M, Tibby SM, Turner C, Ratnavel N, Murdoch IA. Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock. Crit. Care Med.28(7), 2591–2594 (2000).
   PubMed Web of Science ®Google Scholar
• Kopterides P, Siempos II, Tsangaris I, Tsantes A, Armaganidis A. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Crit. Care Med.38(11), 2229–2241 (2010).
   PubMed Web of Science ®Google Scholar
• Stocker M, Fontana M, El Helou S, Wegscheider K, Berger TM. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial. Neonatology97(2), 165–174 (2010).
   PubMed Web of Science ®Google Scholar
• Arkader R, Troster EJ, Abellan DM et al. Procalcitonin and C-reactive protein kinetics in postoperative pediatric cardiac surgical patients. J. Cardiothorac. Vasc. Anesth.18(2), 160–165 (2004).
   PubMed Web of Science ®Google Scholar
• McMaster P, Park DY, Shann F et al. Procalcitonin versus C-reactive protein and immature-to-total neutrophil ratio as markers of infection after cardiopulmonary bypass in children. Pediatr. Crit. Care Med.10(2), 217–221 (2009).
   PubMed Web of Science ®Google Scholar
• Neely AN, Fowler LA, Kagan RJ, Warden GD. Procalcitonin in pediatric burn patients: an early indicator of sepsis? J. Burn Care Rehabil.25(1), 76–80 (2004).
   PubMedGoogle Scholar
• Mann EA, Wood GL, Wade CE. Use of procalcitonin for the detection of sepsis in the critically ill burn patient: a systematic review of the literature. Burns DOI:10.1016/j.burns.2010.04.013 (2010) (Epub ahead of print).
   Google Scholar
• Coelho MCM, Tannuri U, Tannuri ACA, Reingenheim C, Troster EJ. Is procalcitonin useful to differentiate rejection from bacterial infection in the early post-operative period of liver transplantation in children? Pediatr. Transplant.13(8), 1004–1006 (2009).
   PubMed Web of Science ®Google Scholar
• Hatzistilianou M, Rekliti A, Athanassiadou F, Catriu D. Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia. Inflamm. Res.59(5), 339–347 (2010).
   PubMed Web of Science ®Google Scholar
• Kitanovski L, Jazbec J, Hojker S, Gubina M, Derganc M. Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer. Eur. J. Clin. Microbiol. Infect. Dis.25(6), 413–415 (2006).
   PubMed Web of Science ®Google Scholar
• Sauer M, Tiede K, Fuchs D et al. Procalcitonin, C-reactive protein, and endotoxin after bone marrow transplantation: identification of children at high risk of morbidity and mortality from sepsis. Bone Marrow Transplant.31(12), 1137–1142 (2003).
   PubMed Web of Science ®Google Scholar
• Stryjewski GR, Nylen ES, Bell MJ et al. Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children. Pediatr. Crit. Care Med.6(2), 129–135 (2005).
   PubMedGoogle Scholar
• Carrol ED, Mankhambo LA, Jeffers G et al. The diagnostic and prognostic accuracy of five markers of serious bacterial infection in Malawian children with signs of severe infection. PLoS ONE4(8), e6621 (2009).
   PubMed Web of Science ®Google Scholar
• Chiesa C, Panero A, Rossi N et al. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin. Infect. Dis.26(3), 664–672 (1998).
   PubMed Web of Science ®Google Scholar
• Chiesa C, Pacifico L, Rossi N et al. Procalcitonin as a marker of nosocomial infections in the neonatal intensive care unit. Intensive Care Med.26(Suppl. 2), S175–S177 (2000).
   PubMed Web of Science ®Google Scholar
• Monneret G, Labaune JM, Isaac C et al. Procalcitonin and C-reactive protein levels in neonatal infections. Acta Paediatr.86(2), 209–212 (1997).
   PubMed Web of Science ®Google Scholar
• Turner D, Hammerman C, Rudensky B, Schlesinger Y, Schimmel MS. The role of procalcitonin as a predictor of nosocomial sepsis in preterm infants. Acta Paediatr.95(12), 1571–1576 (2006).
   PubMed Web of Science ®Google Scholar
• Resch B, Gusenleitner W, Müller WD. Procalcitonin and interleukin-6 in the diagnosis of early-onset sepsis of the neonate. Acta Paediatr.92(2), 243–245 (2003).
   PubMed Web of Science ®Google Scholar
• Gendrel D, Assicot M, Raymond J et al. Procalcitonin as a marker for the early diagnosis of neonatal infection. J. Pediatr.128(4), 570–573 (1996).
   PubMed Web of Science ®Google Scholar
• Lapillonne A, Basson E, Monneret G, Bienvenu J, Salle BL. Lack of specificity of procalcitonin for sepsis diagnosis in premature infants. Lancet351(9110), 1211–1212 (1998).
   PubMed Web of Science ®Google Scholar
• Monneret G, Labaune JM, Isaac C et al. Increased serum procalcitonin levels are not specific to sepsis in neonates. Clin. Infect. Dis.27(6), 1559–1561 (1998).
   PubMed Web of Science ®Google Scholar
• Turner D, Hammerman C, Rudensky B et al. Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram. Arch. Dis. Child. Fetal Neonatal Ed.91(4), F283–F286 (2006).
   PubMed Web of Science ®Google Scholar
• Bhandari V, Wang C, Rinder C, Rinder H. Hematologic profile of sepsis in neonates: neutrophil CD64 as a diagnostic marker. Pediatrics121(1), 129–134 (2008).
   PubMed Web of Science ®Google Scholar
• Lam HS, Wong SPS, Cheung HM et al. Early diagnosis of intra-abdominal inflammation and sepsis by neutrophil CD64 expression in newborns. Neonatology99(2), 118–124 (2010).
   PubMed Web of Science ®Google Scholar
• Rudensky B, Sirota G, Erlichman M, Yinnon AM, Schlesinger Y. Neutrophil CD64 expression as a diagnostic marker of bacterial infection in febrile children presenting to a hospital emergency department. Pediatr. Emerg. Care24(11), 745–748 (2008).
   PubMed Web of Science ®Google Scholar
• Cid J, Aguinaco R, Sánchez R, García-Pardo G, Llorente A. Neutrophil CD64 expression as marker of bacterial infection: a systematic review and meta-analysis. J. Infect.60(5), 313–319 (2010).
   PubMed Web of Science ®Google Scholar
• Kingsmore SF, Kennedy N, Halliday HL et al. Identification of diagnostic biomarkers for infection in premature neonates. Mol. Cell Proteomics7(10), 1863–1875 (2008).
   PubMed Web of Science ®Google Scholar
• Bender L, Thaarup J, Varming K et al. Early and late markers for the detection of early-onset neonatal sepsis. Dan. Med. Bull.55(4), 219–223 (2008).
   PubMed Web of Science ®Google Scholar
• Mizock BA, Falk JL. Lactic acidosis in critical illness. Crit. Care Med.20(1), 80–93 (1992).
   PubMed Web of Science ®Google Scholar
• Fall PJ, Szerlip HM. Lactic acidosis: from sour milk to septic shock. J. Intensive Care Med.20(5), 255–271 (2005).
   PubMedGoogle Scholar
• Dugas MA, Proulx F, de Jaeger A, Lacroix J, Lambert M. Markers of tissue hypoperfusion in pediatric septic shock. Intensive Care Med.26(1), 75–83 (2000).
   PubMed Web of Science ®Google Scholar
• Mikkelsen ME, Miltiades AN, Gaieski DF et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit. Care Med.37(5), 1670–1677 (2009).
   PubMed Web of Science ®Google Scholar
• Jansen TC, van Bommel J, Bakker J. Blood lactate monitoring in critically ill patients: a systematic health technology assessment. Crit. Care Med.37(10), 2827–2839 (2009).
   PubMed Web of Science ®Google Scholar
• Nguyen HB, Rivers EP, Knoblich BP et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit. Care Med.32(8), 1637–1642 (2004).
   PubMed Web of Science ®Google Scholar
• Brown SD, Clark C, Gutierrez G. Pulmonary lactate release in patients with sepsis and the adult respiratory distress syndrome. J. Crit. Care11(1), 2–8 (1996).
   PubMed Web of Science ®Google Scholar
• James JH, Luchette FA, McCarter FD, Fischer JE. Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet354(9177), 505–508 (1999).
   PubMed Web of Science ®Google Scholar
• Arnold RC, Shapiro NI, Jones AE et al. Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock32(1), 35–39 (2009).
   PubMed Web of Science ®Google Scholar
• Jones AE, Shapiro NI, Trzeciak S et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA303(8), 739–746 (2010).
   PubMed Web of Science ®Google Scholar
• Kofoed K, Andersen O, Kronborg G et al. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care.11(2), R38 (2007).
   PubMed Web of Science ®Google Scholar
• Marshall JC. Sepsis: rethinking the approach to clinical research. J. Leukoc. Biol.83(3), 471–482 (2008).
   PubMed Web of Science ®Google Scholar
• Wong HR, Cvijanovich N, Wheeler DS et al. Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock. Am. J. Respir. Crit. Care Med.178(3), 276–282 (2008).
   PubMed Web of Science ®Google Scholar
• Wong HR, Shanley TP, Sakthivel B et al. Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. Physiol. Genomics30(2), 146–155 (2007).
   PubMed Web of Science ®Google Scholar
• Nadel S, Goldstein B, Williams MD et al. Drotrecogin alfa (activated) in children with severe sepsis: a multicentre Phase III randomised controlled trial. Lancet369(9564), 836–843 (2007).
   PubMed Web of Science ®Google Scholar
• Nowak JE, Wheeler DS, Harmon KK, Wong HR. Admission chemokine (C–C motif) ligand 4 levels predict survival in pediatric septic shock. Pediatr. Crit. Care Med.11(2), 213–216 (2010).
   PubMed Web of Science ®Google Scholar
• Calfee CS, Thompson BT, Parsons PE et al. Plasma interleukin-8 is not an effective risk stratification tool for adults with vasopressor-dependent septic shock. Crit. Care Med.38(6), 1436–1441 (2010).
   PubMed Web of Science ®Google Scholar
• Wong HR, Cvijanovich N, Lin R et al. Identification of pediatric septic shock subclasses based on genome-wide expression profiling. BMC Med.7, 34 (2009).
   PubMed Web of Science ®Google Scholar